Cambridge Antibody Tech Group PLC
8 March 2000
ENTITLEMENT ISSUE
SECURITY TITLE
*Ord Shs
MNEMONIC CODE *CAT
SEDOL CODE *166-225
TERMS *Qualifying shareholders may apply for New Ord Shs, on
a pre-emptive basis, for an amount up to their
respective pro rata entitlements under the Open Offer.
The size of the Open Offer will not be less than £40
million.
The Offer price, which will apply to all applications
for New Ord Shs in the Offers, will be determined at
the end of the International Offering, following a
competitive book-building process. The Offer price &
number of New Ord Shs to be issued will be determined
and announced on 03-04-00.
EX DATE *08-03-00
RECORD DATE *29-02-00
SPLITTING APPLICATION FORMS *29-03-00 4.30 pm
RECEIPT OF APPLICATION FORMS *31-03-00 4.30 pm
DEALING COMMENCE NEW SHARES *04-04-00
NOTES *
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.